• About

  • Blog

  • Position Paper

  • Team

    • Dr. Fernando Aith
    • Dr. Claudio Roberto Cordovil Oliveira
    • Dr. Marina de Neiva Borba
    • Dr. Julino Soares
    • Dr. Conor Douglas
    • Dr. Larry Lynd
    • Dr. Wouter Boon
    • Dr. Jarno Hoekman
    • Dr. Ellen Moors
    • Dr. Rob Hagendijk
    • Dr. Tineke Kleinhout-Vliek
    • Dr. Vololona Rabeharisoa
    • Dr. Florence Paterson
    • Dr. Liliana Doganova
    • Dr. Alexandre Mallard
    • Faisal Ali Mohamed
    • Shir Grunebaum
    • Vanessa Scanga
    • Canadian Team Research Update

  • SPIN2023 Conference

  • Publications

  • Contact Us

  • More

    Use tab to navigate through the menu items.
    • twitter
    WebsiteHeading.png
    EN
    EN
    PT
    To see this working, head to your live site.
    • All Posts
    • My Posts
    SPIN Researcher Team
    Jan 28
    Edited: Jan 28

    Blog Post - Nexviayme Approved For Pompe Disease by Health Canada

    in SPIN Forum

    In this blog post, our Canadian team discusses the approval of Nexviayme for Pompe Disease in the Canadian context.


    https://www.socialpharmaceuticalinnovation.org/post/nexviayme-approved-for-pompe-disease-by-health-canada

    0 comments
    0
    Comments
    Share Your ThoughtsSign up to leave a comment.
    0 comments
    Similar Posts
    • Blog Post - Towards a Canadian National Rare Disease Policy?
    • Blog Post - Is Price Capping an Answer for Expensive Drugs for Rare Diseases in Canada?
    • Blog Post - First Gene Therapy Approved by Health Canada

    Subscribe Form

    cd512@yorku.ca

    • twitter

    ©2020 by Social Pharmaceutical Innovation.